table of content
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2023-2028)
1.4.2 East Asia Market States and Outlook (2023-2028)
1.4.3 Europe Market States and Outlook (2023-2028)
1.4.4 South Asia Market States and Outlook (2023-2028)
1.4.5 Southeast Asia Market States and Outlook (2023-2028)
1.4.6 Middle East Market States and Outlook (2023-2028)
1.4.7 Africa Market States and Outlook (2023-2028)
1.4.8 Oceania Market States and Outlook (2023-2028)
1.4.9 South America Market States and Outlook (2023-2028)
1.5 Global Microneedle-based Drug Delivery System Market Size Analysis from 2023 to 2028
1.5.1 Global Microneedle-based Drug Delivery System Market Size Analysis from 2023 to 2028 by Consumption Volume
1.5.2 Global Microneedle-based Drug Delivery System Market Size Analysis from 2023 to 2028 by Value
1.5.3 Global Microneedle-based Drug Delivery System Price Trends Analysis from 2023 to 2028
1.6 COVID-19 Outbreak: Microneedle-based Drug Delivery System Industry Impact
Chapter 2 Global Microneedle-based Drug Delivery System Competition by Types, Applications, and Top Regions and Countries
2.1 Global Microneedle-based Drug Delivery System (Volume and Value) by Type
2.1.1 Global Microneedle-based Drug Delivery System Consumption and Market Share by Type (2017-2022)
2.1.2 Global Microneedle-based Drug Delivery System Revenue and Market Share by Type (2017-2022)
2.2 Global Microneedle-based Drug Delivery System (Volume and Value) by Application
2.2.1 Global Microneedle-based Drug Delivery System Consumption and Market Share by Application (2017-2022)
2.2.2 Global Microneedle-based Drug Delivery System Revenue and Market Share by Application (2017-2022)
2.3 Global Microneedle-based Drug Delivery System (Volume and Value) by Regions
2.3.1 Global Microneedle-based Drug Delivery System Consumption and Market Share by Regions (2017-2022)
2.3.2 Global Microneedle-based Drug Delivery System Revenue and Market Share by Regions (2017-2022)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2017-2022 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2017-2022 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2017-2022 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global Microneedle-based Drug Delivery System Sales, Consumption, Export, Import by Regions (2017-2022)
4.1 Global Microneedle-based Drug Delivery System Consumption by Regions (2017-2022)
4.2 North America Microneedle-based Drug Delivery System Sales, Consumption, Export, Import (2017-2022)
4.3 East Asia Microneedle-based Drug Delivery System Sales, Consumption, Export, Import (2017-2022)
4.4 Europe Microneedle-based Drug Delivery System Sales, Consumption, Export, Import (2017-2022)
4.5 South Asia Microneedle-based Drug Delivery System Sales, Consumption, Export, Import (2017-2022)
4.6 Southeast Asia Microneedle-based Drug Delivery System Sales, Consumption, Export, Import (2017-2022)
4.7 Middle East Microneedle-based Drug Delivery System Sales, Consumption, Export, Import (2017-2022)
4.8 Africa Microneedle-based Drug Delivery System Sales, Consumption, Export, Import (2017-2022)
4.9 Oceania Microneedle-based Drug Delivery System Sales, Consumption, Export, Import (2017-2022)
4.10 South America Microneedle-based Drug Delivery System Sales, Consumption, Export, Import (2017-2022)
Chapter 5 North America Microneedle-based Drug Delivery System Market Analysis
5.1 North America Microneedle-based Drug Delivery System Consumption and Value Analysis
5.1.1 North America Microneedle-based Drug Delivery System Market Under COVID-19
5.2 North America Microneedle-based Drug Delivery System Consumption Volume by Types
5.3 North America Microneedle-based Drug Delivery System Consumption Structure by Application
5.4 North America Microneedle-based Drug Delivery System Consumption by Top Countries
5.4.1 United States Microneedle-based Drug Delivery System Consumption Volume from 2017 to 2022
5.4.2 Canada Microneedle-based Drug Delivery System Consumption Volume from 2017 to 2022
5.4.3 Mexico Microneedle-based Drug Delivery System Consumption Volume from 2017 to 2022
Chapter 6 East Asia Microneedle-based Drug Delivery System Market Analysis
6.1 East Asia Microneedle-based Drug Delivery System Consumption and Value Analysis
6.1.1 East Asia Microneedle-based Drug Delivery System Market Under COVID-19
6.2 East Asia Microneedle-based Drug Delivery System Consumption Volume by Types
6.3 East Asia Microneedle-based Drug Delivery System Consumption Structure by Application
6.4 East Asia Microneedle-based Drug Delivery System Consumption by Top Countries
6.4.1 China Microneedle-based Drug Delivery System Consumption Volume from 2017 to 2022
6.4.2 Japan Microneedle-based Drug Delivery System Consumption Volume from 2017 to 2022
6.4.3 South Korea Microneedle-based Drug Delivery System Consumption Volume from 2017 to 2022
Chapter 7 Europe Microneedle-based Drug Delivery System Market Analysis
7.1 Europe Microneedle-based Drug Delivery System Consumption and Value Analysis
7.1.1 Europe Microneedle-based Drug Delivery System Market Under COVID-19
7.2 Europe Microneedle-based Drug Delivery System Consumption Volume by Types
7.3 Europe Microneedle-based Drug Delivery System Consumption Structure by Application
7.4 Europe Microneedle-based Drug Delivery System Consumption by Top Countries
7.4.1 Germany Microneedle-based Drug Delivery System Consumption Volume from 2017 to 2022
7.4.2 UK Microneedle-based Drug Delivery System Consumption Volume from 2017 to 2022
7.4.3 France Microneedle-based Drug Delivery System Consumption Volume from 2017 to 2022
7.4.4 Italy Microneedle-based Drug Delivery System Consumption Volume from 2017 to 2022
7.4.5 Russia Microneedle-based Drug Delivery System Consumption Volume from 2017 to 2022
7.4.6 Spain Microneedle-based Drug Delivery System Consumption Volume from 2017 to 2022
7.4.7 Netherlands Microneedle-based Drug Delivery System Consumption Volume from 2017 to 2022
7.4.8 Switzerland Microneedle-based Drug Delivery System Consumption Volume from 2017 to 2022
7.4.9 Poland Microneedle-based Drug Delivery System Consumption Volume from 2017 to 2022
Chapter 8 South Asia Microneedle-based Drug Delivery System Market Analysis
8.1 South Asia Microneedle-based Drug Delivery System Consumption and Value Analysis
8.1.1 South Asia Microneedle-based Drug Delivery System Market Under COVID-19
8.2 South Asia Microneedle-based Drug Delivery System Consumption Volume by Types
8.3 South Asia Microneedle-based Drug Delivery System Consumption Structure by Application
8.4 South Asia Microneedle-based Drug Delivery System Consumption by Top Countries
8.4.1 India Microneedle-based Drug Delivery System Consumption Volume from 2017 to 2022
8.4.2 Pakistan Microneedle-based Drug Delivery System Consumption Volume from 2017 to 2022
8.4.3 Bangladesh Microneedle-based Drug Delivery System Consumption Volume from 2017 to 2022
Chapter 9 Southeast Asia Microneedle-based Drug Delivery System Market Analysis
9.1 Southeast Asia Microneedle-based Drug Delivery System Consumption and Value Analysis
9.1.1 Southeast Asia Microneedle-based Drug Delivery System Market Under COVID-19
9.2 Southeast Asia Microneedle-based Drug Delivery System Consumption Volume by Types
9.3 Southeast Asia Microneedle-based Drug Delivery System Consumption Structure by Application
9.4 Southeast Asia Microneedle-based Drug Delivery System Consumption by Top Countries
9.4.1 Indonesia Microneedle-based Drug Delivery System Consumption Volume from 2017 to 2022
9.4.2 Thailand Microneedle-based Drug Delivery System Consumption Volume from 2017 to 2022
9.4.3 Singapore Microneedle-based Drug Delivery System Consumption Volume from 2017 to 2022
9.4.4 Malaysia Microneedle-based Drug Delivery System Consumption Volume from 2017 to 2022
9.4.5 Philippines Microneedle-based Drug Delivery System Consumption Volume from 2017 to 2022
9.4.6 Vietnam Microneedle-based Drug Delivery System Consumption Volume from 2017 to 2022
9.4.7 Myanmar Microneedle-based Drug Delivery System Consumption Volume from 2017 to 2022
Chapter 10 Middle East Microneedle-based Drug Delivery System Market Analysis
10.1 Middle East Microneedle-based Drug Delivery System Consumption and Value Analysis
10.1.1 Middle East Microneedle-based Drug Delivery System Market Under COVID-19
10.2 Middle East Microneedle-based Drug Delivery System Consumption Volume by Types
10.3 Middle East Microneedle-based Drug Delivery System Consumption Structure by Application
10.4 Middle East Microneedle-based Drug Delivery System Consumption by Top Countries
10.4.1 Turkey Microneedle-based Drug Delivery System Consumption Volume from 2017 to 2022
10.4.2 Saudi Arabia Microneedle-based Drug Delivery System Consumption Volume from 2017 to 2022
10.4.3 Iran Microneedle-based Drug Delivery System Consumption Volume from 2017 to 2022
10.4.4 United Arab Emirates Microneedle-based Drug Delivery System Consumption Volume from 2017 to 2022
10.4.5 Israel Microneedle-based Drug Delivery System Consumption Volume from 2017 to 2022
10.4.6 Iraq Microneedle-based Drug Delivery System Consumption Volume from 2017 to 2022
10.4.7 Qatar Microneedle-based Drug Delivery System Consumption Volume from 2017 to 2022
10.4.8 Kuwait Microneedle-based Drug Delivery System Consumption Volume from 2017 to 2022
10.4.9 Oman Microneedle-based Drug Delivery System Consumption Volume from 2017 to 2022
Chapter 11 Africa Microneedle-based Drug Delivery System Market Analysis
11.1 Africa Microneedle-based Drug Delivery System Consumption and Value Analysis
11.1.1 Africa Microneedle-based Drug Delivery System Market Under COVID-19
11.2 Africa Microneedle-based Drug Delivery System Consumption Volume by Types
11.3 Africa Microneedle-based Drug Delivery System Consumption Structure by Application
11.4 Africa Microneedle-based Drug Delivery System Consumption by Top Countries
11.4.1 Nigeria Microneedle-based Drug Delivery System Consumption Volume from 2017 to 2022
11.4.2 South Africa Microneedle-based Drug Delivery System Consumption Volume from 2017 to 2022
11.4.3 Egypt Microneedle-based Drug Delivery System Consumption Volume from 2017 to 2022
11.4.4 Algeria Microneedle-based Drug Delivery System Consumption Volume from 2017 to 2022
11.4.5 Morocco Microneedle-based Drug Delivery System Consumption Volume from 2017 to 2022
Chapter 12 Oceania Microneedle-based Drug Delivery System Market Analysis
12.1 Oceania Microneedle-based Drug Delivery System Consumption and Value Analysis
12.2 Oceania Microneedle-based Drug Delivery System Consumption Volume by Types
12.3 Oceania Microneedle-based Drug Delivery System Consumption Structure by Application
12.4 Oceania Microneedle-based Drug Delivery System Consumption by Top Countries
12.4.1 Australia Microneedle-based Drug Delivery System Consumption Volume from 2017 to 2022
12.4.2 New Zealand Microneedle-based Drug Delivery System Consumption Volume from 2017 to 2022
Chapter 13 South America Microneedle-based Drug Delivery System Market Analysis
13.1 South America Microneedle-based Drug Delivery System Consumption and Value Analysis
13.1.1 South America Microneedle-based Drug Delivery System Market Under COVID-19
13.2 South America Microneedle-based Drug Delivery System Consumption Volume by Types
13.3 South America Microneedle-based Drug Delivery System Consumption Structure by Application
13.4 South America Microneedle-based Drug Delivery System Consumption Volume by Major Countries
13.4.1 Brazil Microneedle-based Drug Delivery System Consumption Volume from 2017 to 2022
13.4.2 Argentina Microneedle-based Drug Delivery System Consumption Volume from 2017 to 2022
13.4.3 Columbia Microneedle-based Drug Delivery System Consumption Volume from 2017 to 2022
13.4.4 Chile Microneedle-based Drug Delivery System Consumption Volume from 2017 to 2022
13.4.5 Venezuela Microneedle-based Drug Delivery System Consumption Volume from 2017 to 2022
13.4.6 Peru Microneedle-based Drug Delivery System Consumption Volume from 2017 to 2022
13.4.7 Puerto Rico Microneedle-based Drug Delivery System Consumption Volume from 2017 to 2022
13.4.8 Ecuador Microneedle-based Drug Delivery System Consumption Volume from 2017 to 2022
Chapter 14 Company Profiles and Key Figures in Microneedle-based Drug Delivery System Business
14.1 3M
14.1.1 3M Company Profile
14.1.2 3M Microneedle-based Drug Delivery System Product Specification
14.1.3 3M Microneedle-based Drug Delivery System Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.2 Microdermics
14.2.1 Microdermics Company Profile
14.2.2 Microdermics Microneedle-based Drug Delivery System Product Specification
14.2.3 Microdermics Microneedle-based Drug Delivery System Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.3 Nanopass Technologies
14.3.1 Nanopass Technologies Company Profile
14.3.2 Nanopass Technologies Microneedle-based Drug Delivery System Product Specification
14.3.3 Nanopass Technologies Microneedle-based Drug Delivery System Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.4 Zosano Pharma
14.4.1 Zosano Pharma Company Profile
14.4.2 Zosano Pharma Microneedle-based Drug Delivery System Product Specification
14.4.3 Zosano Pharma Microneedle-based Drug Delivery System Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.5 Nitto
14.5.1 Nitto Company Profile
14.5.2 Nitto Microneedle-based Drug Delivery System Product Specification
14.5.3 Nitto Microneedle-based Drug Delivery System Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.6 Becton-Dickinson?BD?Technologies
14.6.1 Becton-Dickinson?BD?Technologies Company Profile
14.6.2 Becton-Dickinson?BD?Technologies Microneedle-based Drug Delivery System Product Specification
14.6.3 Becton-Dickinson?BD?Technologies Microneedle-based Drug Delivery System Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.7 Vaxxas
14.7.1 Vaxxas Company Profile
14.7.2 Vaxxas Microneedle-based Drug Delivery System Product Specification
14.7.3 Vaxxas Microneedle-based Drug Delivery System Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.8 Valeritas
14.8.1 Valeritas Company Profile
14.8.2 Valeritas Microneedle-based Drug Delivery System Product Specification
14.8.3 Valeritas Microneedle-based Drug Delivery System Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.9 Corium
14.9.1 Corium Company Profile
14.9.2 Corium Microneedle-based Drug Delivery System Product Specification
14.9.3 Corium Microneedle-based Drug Delivery System Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.10 TheraJect
14.10.1 TheraJect Company Profile
14.10.2 TheraJect Microneedle-based Drug Delivery System Product Specification
14.10.3 TheraJect Microneedle-based Drug Delivery System Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.11 Lohmann Therapie-Systeme AG
14.11.1 Lohmann Therapie-Systeme AG Company Profile
14.11.2 Lohmann Therapie-Systeme AG Microneedle-based Drug Delivery System Product Specification
14.11.3 Lohmann Therapie-Systeme AG Microneedle-based Drug Delivery System Production Capacity, Revenue, Price and Gross Margin (2017-2022)
Chapter 15 Global Microneedle-based Drug Delivery System Market Forecast (2023-2028)
15.1 Global Microneedle-based Drug Delivery System Consumption Volume, Revenue and Price Forecast (2023-2028)
15.1.1 Global Microneedle-based Drug Delivery System Consumption Volume and Growth Rate Forecast (2023-2028)
15.1.2 Global Microneedle-based Drug Delivery System Value and Growth Rate Forecast (2023-2028)
15.2 Global Microneedle-based Drug Delivery System Consumption Volume, Value and Growth Rate Forecast by Region (2023-2028)
15.2.1 Global Microneedle-based Drug Delivery System Consumption Volume and Growth Rate Forecast by Regions (2023-2028)
15.2.2 Global Microneedle-based Drug Delivery System Value and Growth Rate Forecast by Regions (2023-2028)
15.2.3 North America Microneedle-based Drug Delivery System Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.4 East Asia Microneedle-based Drug Delivery System Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.5 Europe Microneedle-based Drug Delivery System Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.6 South Asia Microneedle-based Drug Delivery System Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.7 Southeast Asia Microneedle-based Drug Delivery System Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.8 Middle East Microneedle-based Drug Delivery System Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.9 Africa Microneedle-based Drug Delivery System Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.10 Oceania Microneedle-based Drug Delivery System Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.11 South America Microneedle-based Drug Delivery System Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.3 Global Microneedle-based Drug Delivery System Consumption Volume, Revenue and Price Forecast by Type (2023-2028)
15.3.1 Global Microneedle-based Drug Delivery System Consumption Forecast by Type (2023-2028)
15.3.2 Global Microneedle-based Drug Delivery System Revenue Forecast by Type (2023-2028)
15.3.3 Global Microneedle-based Drug Delivery System Price Forecast by Type (2023-2028)
15.4 Global Microneedle-based Drug Delivery System Consumption Volume Forecast by Application (2023-2028)
15.5 Microneedle-based Drug Delivery System Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology
